Table 1.
Trapezius group N = 19 | Deltoid group N = 18 | p* | |
---|---|---|---|
Median (range) or % (N) | |||
Subject characteristics | |||
Age (in years) | 25 (19–35) | 24.5 (19–32) | 0.702 |
Female sex | 100.0 (19) | 94.4 (17) | 0.978 |
Headache diary of the DMKG (assessed daily over the course of 90 days before and after intervention) | |||
Number of days with headache | 23 (17–37) | 20 (15–40) | 0.057 |
Cumulative headache duration (hours) | 194 (78–429) | 121 (60–482) | 0.448 |
Duration per headache attack (hours) | 6.8 (4.0–14.8) | 6.1 (3.3–19.3) | 0.988 |
Average headache intensity (according to VAS) | 5.3 (3.5–6.9) | 5.2 (3.9–6.5) | 0.727 |
Vomiting (incidences per 90 days) | 0 (0–4) | 0 (0–9) | 0.521 |
Nausea (incidences per 90 days) | 7 (0–25) | 5 (0–16) | 0.344 |
Medication (intake per 90 days) | 12 (0–29) | 11 (3–27) | 0.927 |
MIDAS questionnaire (assessed for the 90 days before and after intervention) | |||
Missing school/work (days) | 1 (0–5) | 1 (0–12) | 0.405 |
Productivity at school/work reduced by half (days) | 10 (2–20) | 7.5 (3–23) | 0.247 |
Could not do household work (days) | 5 (0–11) | 4.5 (0–18) | 0.903 |
Household work productivity reduced by half (days) | 5 (0–15) | 6 (0–14) | 0.843 |
Missing family, social, or leisure activities (days) | 3 (0–10) | 4.5 (0–17) | 0.375 |
*Wilcoxon signed-rank test or Chi-squared test.